John Overdeck’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
+851,348
New +$1.74M ﹤0.01% 3166
2025
Q3
Sell
-113,262
Closed -$274K 3779
2025
Q2
$274K Sell
113,262
-97,104
-46% -$132K ﹤0.01% 2823
2025
Q1
$173K Sell
210,366
-119,840
-36% -$114K ﹤0.01% 2881
2024
Q4
$281K Sell
330,206
-78,313
-19% -$87.1K ﹤0.01% 2756
2024
Q3
$507K Sell
408,519
-69,923
-15% -$87.5K ﹤0.01% 2468
2024
Q2
$799K Sell
478,442
-97,138
-17% -$174K ﹤0.01% 2109
2024
Q1
$1.07M Buy
575,580
+679
+0.1% +$1.25K ﹤0.01% 1921
2023
Q4
$1.09M Buy
574,901
+110,175
+24% +$165K ﹤0.01% 2020
2023
Q3
$613K Buy
464,726
+116,695
+34% +$256K ﹤0.01% 2191
2023
Q2
$1.04M Buy
348,031
+109,336
+46% +$351K ﹤0.01% 1928
2023
Q1
$826K Sell
238,695
-175,833
-42% -$852K ﹤0.01% 1967
2022
Q4
$1.73M Sell
414,528
-59,051
-12% -$224K 0.01% 1395
2022
Q3
$1.9M Buy
473,579
+425,279
+880% +$3.23M 0.01% 1173
2022
Q2
$546K Sell
48,300
-487,296
-91% -$5.84M ﹤0.01% 1792
2022
Q1
$8.7M Buy
535,596
+417,060
+352% +$10.7M 0.03% 663
2021
Q4
$5.62M Buy
118,536
+111,166
+1,508% +$6.67M 0.01% 1125
2021
Q3
$534K Buy
+7,370
New +$533K ﹤0.01% 3194
2021
Q1
Sell
-23,618
Closed -$1.11M 4015
2020
Q4
$1.11M Buy
+23,618
New +$930K ﹤0.01% 1908

Other funds holding NBP

John Overdeck's NBP Position: Q2 2026 in Review

John Overdeck opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 851,348 shares worth $1.66M. The stake represents ﹤0.01% of the portfolio and ranks #3166 among its holdings. This is a return to the name: John Overdeck previously reported a position in NBP as recently as Q2 2025.

John Overdeck first reported a position in NBP in Q4 2020 and has held it in 18 quarters since. The position peaked at $8.7M in Q1 2022. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • John Overdeck held 851,348 shares of NovaBridge Biosciences American Depositary Shares worth $1.66M as of Q2 2026.
  • NovaBridge Biosciences American Depositary Shares was a new John Overdeck position in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3166 holding.
  • John Overdeck first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 18 quarters since.
  • John Overdeck's NovaBridge Biosciences American Depositary Shares position peaked at $8.7M in Q1 2022.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.